Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| BridgeBio Pharma, Inc.NOTE 1 750 3 0(BBIO) | 0 | 250,000 | +250,000 | $0 | $18.57M | 7.67% | +$18.57M |
| Viking Therapeutics, Inc.(VKTX) | 336,849 | 525,181 | +188,332 | $11.85M | $17.09M | 7.06% | +$5.24M |
| United Therapeutics Corporation(UTHR) | 10,000 | 27,303 | +17,303 | $4.87M | $16.19M | 6.69% | +$11.32M |
| Johnson & Johnson(JNJ) | 66,444 | 53,771 | -12,673 | $13.75M | $13.14M | 5.43% | -$606.8K |
| Cogent Biosciences, Inc.(COGT) | 131,852 | 322,764 | +190,912 | $4.68M | $12.42M | 5.13% | +$7.74M |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 0 | 54,755 | +54,755 | $0 | $10.35M | 4.27% | +$10.35M |
| Terns Pharmaceuticals Inc | 345,880 | 181,752 | -164,128 | $13.97M | $9.58M | 3.96% | -$4.39M |
| BioMarin Pharmaceutical Inc.(BMRN) | 146,361 | 148,229 | +1,868 | $8.70M | $8.37M | 3.46% | -$324.8K |
| ABIVAX Société AnonymeADS(ABVX) | 75,644 | 75,944 | +300 | $10.20M | $8.22M | 3.39% | -$1.98M |
| Revolution Medicines, Inc.(RVMD) | 37,020 | 80,872 | +43,852 | $2.95M | $7.86M | 3.25% | +$4.92M |
| Kodiak Sciences Inc.(KOD) | 0 | 192,962 | +192,962 | $0 | $7.36M | 3.04% | +$7.36M |
| Incyte Corporation(INCY) | 0 | 78,029 | +78,029 | $0 | $7.34M | 3.03% | +$7.34M |
| TG Therapeutics, Inc.(TGTX) | 123,283 | 206,928 | +83,645 | $3.68M | $6.87M | 2.84% | +$3.20M |
| BridgeBio Pharma, Inc.(BBIO) | 70,000 | 85,311 | +15,311 | $5.35M | $6.34M | 2.62% | +$980.9K |
| Immunocore Holdings plcADS(IMCR) | 70,300 | 193,189 | +122,889 | $2.44M | $5.82M | 2.41% | +$3.38M |
| Eli Lilly and Company(LLY) | 2,000 | 6,000 | +4,000 | $2.15M | $5.52M | 2.28% | +$3.37M |
| AbbVie Inc.(ABBV) | 0 | 24,058 | +24,058 | $0 | $5.23M | 2.16% | +$5.23M |
| Arcus Biosciences, Inc.(RCUS) | 0 | 238,142 | +238,142 | $0 | $5.14M | 2.12% | +$5.14M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 0 | 439,957 | +439,957 | $0 | $4.13M | 1.71% | +$4.13M |
| Corvus Pharmaceuticals, Inc.(CRVS) | 0 | 244,811 | +244,811 | $0 | $3.58M | 1.48% | +$3.58M |
| Zymeworks Inc.(ZYME) | 0 | 142,132 | +142,132 | $0 | $3.56M | 1.47% | +$3.56M |
| Structure Therapeutics IncADS | 0 | 72,234 | +72,234 | $0 | $3.48M | 1.44% | +$3.48M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 62,281 | 187,307 | +125,026 | $976.6K | $3.08M | 1.27% | +$2.10M |
| Tenax Therapeutics, Inc.(TENX) | 243,170 | 179,738 | -63,432 | $2.96M | $2.87M | 1.19% | -$90.2K |
| Harmony Biosciences Holdings, Inc.(HRMY) | 7,500 | 92,864 | +85,364 | $280.6K | $2.60M | 1.07% | +$2.32M |
| Capricor Therapeutics, Inc.(CAPR) | 158,075 | 78,851 | -79,224 | $4.56M | $2.40M | 0.99% | -$2.16M |
| EyePoint, Inc.(EYPT) | 0 | 178,545 | +178,545 | $0 | $2.30M | 0.95% | +$2.30M |
| Bicycle Therapeutics PlcADS | 0 | 476,424 | +476,424 | $0 | $2.21M | 0.91% | +$2.21M |
| Indivior Pharmaceuticals, Inc.(INDV) | 0 | 71,376 | +71,376 | $0 | $2.18M | 0.90% | +$2.18M |
| Climb Bio, Inc.(CLYM) | 0 | 286,126 | +286,126 | $0 | $1.96M | 0.81% | +$1.96M |
| Inventiva S.A.ADS(IVA) | 334,251 | 352,399 | +18,148 | $1.55M | $1.94M | 0.80% | +$380.8K |
| Shattuck Labs, Inc.(STTK) | 0 | 293,664 | +293,664 | $0 | $1.89M | 0.78% | +$1.89M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 0 | 25,942 | +25,942 | $0 | $1.82M | 0.75% | +$1.82M |
| Alkermes plcSHS(ALKS) | 0 | 50,000 | +50,000 | $0 | $1.77M | 0.73% | +$1.77M |
| MacroGenics, Inc.(MGNX) | 0 | 600,000 | +600,000 | $0 | $1.73M | 0.72% | +$1.73M |
| Vertex Pharmaceuticals Incorporated(VRTX) | 10,000 | 3,840 | -6,160 | $4.53M | $1.71M | 0.71% | -$2.82M |
| Voyager Therapeutics, Inc.(VYGR) | 0 | 423,642 | +423,642 | $0 | $1.64M | 0.68% | +$1.64M |
| Vaxcyte, Inc.(PCVX) | 22,972 | 25,071 | +2,099 | $1.06M | $1.46M | 0.60% | +$396.9K |
| Relmada Therapeutics, Inc.(RLMD) | 389,395 | 200,842 | -188,553 | $1.88M | $1.40M | 0.58% | -$482.9K |
| BioAge Labs, Inc.(BIOA) | 271,164 | 60,000 | -211,164 | $3.59M | $1.05M | 0.43% | -$2.54M |
| Inovio Pharmaceuticals, Inc.(INO) | 533,682 | 562,665 | +28,983 | $928.6K | $979.0K | 0.40% | +$50.4K |
| Aytu Biopharma Inc | 305,788 | 353,077 | +47,289 | $795.0K | $963.9K | 0.40% | +$168.9K |
| Equillium, Inc.(EQ) | 347,393 | 433,844 | +86,451 | $538.5K | $867.7K | 0.36% | +$329.2K |
| Dianthus Therapeutics, Inc.(DNTH) | 0 | 10,000 | +10,000 | $0 | $839.2K | 0.35% | +$839.2K |
| Pharvaris N V COM | 0 | 29,321 | +29,321 | $0 | $828.3K | 0.34% | +$828.3K |
| Enanta Pharmaceuticals, Inc.(ENTA) | 65,138 | 64,952 | -186 | $1.03M | $820.3K | 0.34% | -$206.9K |
| Replimune Group, Inc.(REPL) | 230,997 | 100,660 | -130,337 | $2.25M | $770.0K | 0.32% | -$1.48M |
| Xeris Biopharma Holdings Inc | 170,568 | 132,746 | -37,822 | $1.34M | $769.9K | 0.32% | -$569.0K |
| Larimar Therapeutics, Inc.(LRMR) | 0 | 166,637 | +166,637 | $0 | $749.9K | 0.31% | +$749.9K |
| Annexon, Inc.(ANNX) | 350,000 | 132,916 | -217,084 | $1.76M | $736.4K | 0.30% | -$1.02M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 0 | 35,144 | +35,144 | $0 | $736.3K | 0.30% | +$736.3K |
| Mineralys Therapeutics, Inc.(MLYS) | 25,000 | 26,347 | +1,347 | $907.3K | $713.7K | 0.29% | -$193.5K |
| Unicycive Therapeutics, Inc.(UNCY) | 0 | 106,083 | +106,083 | $0 | $698.0K | 0.29% | +$698.0K |
| Spruce Biosciences Inc | 0 | 10,000 | +10,000 | $0 | $653.5K | 0.27% | +$653.5K |
| Phathom Pharmaceuticals, Inc.(PHAT) | 0 | 54,650 | +54,650 | $0 | $607.2K | 0.25% | +$607.2K |
| Celcuity Inc.(CELC) | 0 | 5,314 | +5,314 | $0 | $606.5K | 0.25% | +$606.5K |
| Connect Biopharma Holdings LimitedSHS(CNTB) | 0 | 200,690 | +200,690 | $0 | $525.8K | 0.22% | +$525.8K |
| Novo Nordisk A/SADR(NVO) | 0 | 14,577 | +14,577 | $0 | $520.7K | 0.22% | +$520.7K |
| Pelthos Therapeutics Inc.(PTHS) | 25,000 | 24,773 | -227 | $775.0K | $520.5K | 0.21% | -$254.5K |
| uniQure N.V.SHS(QURE) | 45,000 | 31,200 | -13,800 | $1.08M | $510.1K | 0.21% | -$566.7K |
| MannKind Corporation(MNKD) | 302,000 | 186,603 | -115,397 | $1.71M | $457.2K | 0.19% | -$1.26M |
| Maze Therapeutics, Inc.(MAZE) | 0 | 15,000 | +15,000 | $0 | $447.8K | 0.18% | +$447.8K |
| UroGen Pharma Ltd.(URGN) | 21,810 | 23,155 | +1,345 | $510.8K | $416.3K | 0.17% | -$94.5K |
| Corcept Therapeutics Incorporated(CORT) | 97,445 | 10,000 | -87,445 | $3.39M | $403.1K | 0.17% | -$2.99M |
| Lipocine Inc.(LPCN) | 260,939 | 50,000 | -210,939 | $2.10M | $399.5K | 0.16% | -$1.70M |
| Foghorn Therapeutics Inc.(FHTX) | 30,630 | 79,944 | +49,314 | $165.4K | $382.1K | 0.16% | +$216.7K |
| GH Research PLC(GHRS) | 0 | 26,836 | +26,836 | $0 | $377.3K | 0.16% | +$377.3K |
| Ocugen, Inc.(OCGN) | 0 | 200,000 | +200,000 | $0 | $362.0K | 0.15% | +$362.0K |
| Proqr Thrapeutics N VSHS EURO SHS EURO | 167,532 | 180,083 | +12,551 | $338.4K | $291.7K | 0.12% | -$46.7K |
| Eupraxia Pharmaceuticals Inc.(EPRX) | 0 | 40,000 | +40,000 | $0 | $289.6K | 0.12% | +$289.6K |
| PepGen Inc.(PEPG) | 0 | 150,925 | +150,925 | $0 | $267.1K | 0.11% | +$267.1K |
| Trevi Therapeutics, Inc.(TRVI) | 97,184 | 21,663 | -75,521 | $1.22M | $258.4K | 0.11% | -$958.3K |
| Precigen, Inc.(PGEN) | 0 | 55,293 | +55,293 | $0 | $214.0K | 0.09% | +$214.0K |
| Upstream Bio, Inc.(UPB) | 20,500 | 21,609 | +1,109 | $556.6K | $194.5K | 0.08% | -$362.1K |
| COMPASS Pathways plcADS(CMPS) | 0 | 31,885 | +31,885 | $0 | $176.3K | 0.07% | +$176.3K |
| Passage Bio, Inc.(PASG) | 0 | 19,530 | +19,530 | $0 | $153.3K | 0.06% | +$153.3K |
| Talphera, Inc.(TLPH) | 136,923 | 153,563 | +16,640 | $156.1K | $114.7K | 0.05% | -$41.4K |
| Rocket Pharmaceuticals, Inc.(RCKT) | 0 | 30,579 | +30,579 | $0 | $109.5K | 0.05% | +$109.5K |
| Monopar Therapeutics Inc.(MNPR) | 0 | 1,630 | +1,630 | $0 | $89.3K | 0.04% | +$89.3K |
| Vistagen Therapeutics, Inc.(VTGN) | 100,000 | 105,428 | +5,428 | $66.2K | $60.3K | 0.02% | -$5.9K |
| Atrium Therapeutics, Inc.(RNA) | 0 | 2,512 | +2,512 | $0 | $33.6K | 0.01% | +$33.6K |
| Cue Biopharma, Inc.(CUE) | 0 | 131,997 | +131,997 | $0 | $30.3K | 0.01% | +$30.3K |
| Entera Bio Ltd.SHS(ENTX) | 0 | 23,260 | +23,260 | $0 | $25.8K | 0.01% | +$25.8K |
| PureTech Health plcADS(PRTCY) | 7,442 | 7,924 | +482 | $123.8K | $11.3K | 0.00% | -$112.5K |
| Enliven Therapeutics Inc | 0 | 245 | +245 | $0 | $9.6K | 0.00% | +$9.6K |
| Septerna, Inc.(SEPN) | 0 | 202 | +202 | $0 | $4.9K | 0.00% | +$4.9K |
| Aardvark Therapeutics Inc | 15,882 | 0 | -15,882 | $208.5K | $0 | — | -$208.5K |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 5,341 | 0 | -5,341 | $2.12M | $0 | — | -$2.12M |
| ANI Pharmaceuticals, Inc.(ANIP) | 53,354 | 0 | -53,354 | $4.21M | $0 | — | -$4.21M |
| Ardelyx Inc | 252,198 | 0 | -252,198 | $1.47M | $0 | — | -$1.47M |
| Ascendis Pharma A/SADR(ASND) | 6,840 | 0 | -6,840 | $1.46M | $0 | — | -$1.46M |
| BeOne Medicines AGADS(ONC) | 7,500 | 0 | -7,500 | $172.8K | $0 | — | -$172.8K |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 190,928 | 0 | -190,928 | $1.49M | $0 | — | -$1.49M |
| Centessa Pharmaceuticals PlcADS | 90,000 | 0 | -90,000 | $2.25M | $0 | — | -$2.25M |
| Design Therapeutics, Inc.(DSGN) | 100,320 | 0 | -100,320 | $941.0K | $0 | — | -$941.0K |
| Edesa Biotech, Inc.(EDSA) | 54,025 | 0 | -54,025 | $76.7K | $0 | — | -$76.7K |
| Edgewise Therapeutics, Inc.(EWTX) | 30,000 | 0 | -30,000 | $744.5K | $0 | — | -$744.5K |
| Immunome, Inc.(IMNM) | 22,500 | 0 | -22,500 | $483.3K | $0 | — | -$483.3K |
| Indivior Plc | 17,320 | 0 | -17,320 | $621.4K | $0 | — | -$621.4K |
| Inhibrx Biosciences, Inc.(INBX) | 1,299 | 0 | -1,299 | $102.6K | $0 | — | -$102.6K |